Kaya Firat

9PUBLICATIONS
51CO-AUTHORS
Medical mycologyPredictive and prognostic markersPharmaceutical delivery technologiesMedical virologyMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 13, 2026
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis.

Brendan M Crowley, Helena I Boshoff, Aidan Boving

|Jan 07, 2026
PET/CT imaging of tuberculosis lung lesions in marmosets treated with different drug regimens aligns with human clinical outcomes.

Talia Greenstein, Laura E Via, Mariana Pereira Moraes

|Jun 04, 2025
The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of Resistance.

Annamarie E Bustion, Jacqueline P Ernest, Firat Kaya

|May 01, 2025
Next-generation rifamycins for the treatment of mycobacterial infections.

Véronique Dartois, Tian Lan, Uday S Ganapathy

|Apr 06, 2024
Mtb-Selective 5-Aminomethyl Oxazolidinone Prodrugs: Robust Potency and Potential Liabilities.

Helena I M Boshoff, Katherine Young, Yong-Mo Ahn

|Jan 17, 2024
Commensal antimicrobial resistance mediates microbiome resilience to antibiotic disruption.

Shakti K Bhattarai, Muxue Du, Abigail L Zeamer

Pageof 2